The Limited Times

Now you can see non-English news...

The transformation of the Swiss laboratory Novartis is slow to convince

2023-02-01T18:35:34.223Z


Five years after Vas Narasimhan took office, investors are pushing him to go faster. "We are on the right path. Our project is a long-term one, with the objective of eventually becoming the most reliable and esteemed pharmaceutical company in the world . Vas Narasimhan , CEO of Novartis (50.5 billion dollars in turnover in 2022), who presented his annual results on Wednesday, is still struggling to convince of the change initiated by the Swiss laboratory. Five years after taking o


"We are on the right path.

Our project is a long-term one, with the objective of eventually becoming the most reliable and esteemed pharmaceutical company in the world

.

Vas Narasimhan

, CEO of Novartis (50.5 billion dollars in turnover in 2022), who presented his annual results on Wednesday, is still struggling to convince of the change initiated by the Swiss laboratory.

Five years after taking office, many investors consider the transformation of Big Pharma still too slow.

The stock market performance of the Novartis stock (-11% in three years), well below those of the heavyweights in the sector, illustrates this skepticism.

Some even gave “Go” a year ago.

When he took over in 2018, Vas Narasimhan, 41, was Big Pharma's youngest boss.

The appointment of this doctor of Indian origin, former head of R&D at Novartis, raises many hopes.

The Swiss laboratory then appears as a “conglomerate”.

Novartis, which missed…

This article is for subscribers only.

You have 68% left to discover.

Want to read more?

Unlock all items immediately.

Without engagement.

TEST FOR €0.99

Already subscribed?

Login

Source: lefigaro

All business articles on 2023-02-01

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.